Monoclonal Antibodies for Enhancing or Inhibiting Insulin-Like Growth Factor 1

David R. Clemmons (Inventor), Laura A. Maile (Inventor)

Research output: ResearchPatent

Abstract

The present invention provides .alpha.V.beta.3 integrin cysteine loop domain agonists and antagonists (including peptide agonists and antagonists and analogs thereof), along with methods of using the same.
LanguageEnglish
Patent number8187595
IPCA61K 39/395 (20060101)
StatePublished - 1800

Fingerprint

Somatomedins
Integrins
Cysteine
Monoclonal Antibodies
Peptides

Cite this

Clemmons, D. R., & Maile, L. A. (1800). IPC No. A61K 39/395 (20060101). Monoclonal Antibodies for Enhancing or Inhibiting Insulin-Like Growth Factor 1 (Patent No. 8187595.)

Monoclonal Antibodies for Enhancing or Inhibiting Insulin-Like Growth Factor 1. / Clemmons, David R. (Inventor); Maile, Laura A. (Inventor).

IPC No.: A61K 39/395 (20060101). Patent No.: 8187595.

Research output: ResearchPatent

Clemmons, DR & Maile, LA 1800, Monoclonal Antibodies for Enhancing or Inhibiting Insulin-Like Growth Factor 1, Patent No. 8187595, IPC No. A61K 39/395 (20060101).
Clemmons, David R. (Inventor) ; Maile, Laura A. (Inventor). / Monoclonal Antibodies for Enhancing or Inhibiting Insulin-Like Growth Factor 1. IPC No.: A61K 39/395 (20060101). Patent No.: 8187595.
@misc{2b1bfb07c55b4bfca05839a8945eeb95,
title = "Monoclonal Antibodies for Enhancing or Inhibiting Insulin-Like Growth Factor 1",
abstract = "The present invention provides .alpha.V.beta.3 integrin cysteine loop domain agonists and antagonists (including peptide agonists and antagonists and analogs thereof), along with methods of using the same.",
author = "Clemmons, {David R.} and Maile, {Laura A.}",
note = "Status: published applicationnumber: 12/498,719 usclass: 424/130.1 ; 424/141.1; 424/178.1 applicationnumber: 12/498,719; 8187595; A61K 39/395 (20060101)",
year = "1800",
type = "Patent",

}

TY - PAT

T1 - Monoclonal Antibodies for Enhancing or Inhibiting Insulin-Like Growth Factor 1

AU - Clemmons,David R.

AU - Maile,Laura A.

N1 - Status: published applicationnumber: 12/498,719 usclass: 424/130.1 ; 424/141.1; 424/178.1 applicationnumber: 12/498,719

PY - 1800

Y1 - 1800

N2 - The present invention provides .alpha.V.beta.3 integrin cysteine loop domain agonists and antagonists (including peptide agonists and antagonists and analogs thereof), along with methods of using the same.

AB - The present invention provides .alpha.V.beta.3 integrin cysteine loop domain agonists and antagonists (including peptide agonists and antagonists and analogs thereof), along with methods of using the same.

M3 - Patent

M1 - 8187595

ER -